AKT1 and Cognitive impairment: Accordingly, there is accumulating evidence that the beneficial effects of various compounds on the diabetes-induced cognitive deficits are due to a re-established activation of the PI3K/Akt/mTOR pathway and reduced oxidative stress, neuroinflammation, and autophagy [188,189,190,191,192].